Literature DB >> 30049617

Assessing the risk of dolutegravir for women of childbearing potential.

Michael Schomaker1, Mary-Ann Davies2, Morna Cornell2, Nathan Ford3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30049617     DOI： 10.1016/S2214-109X(18)30326-7

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  5 in total

1.  Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.

Authors:  Claudia S Crowell; Paige L Williams; Cenk Yildirim; Russell B Van Dyke; Renee Smith; Ellen G Chadwick; George R Seage; Alexandria Diperna; Rohan Hazra
Journal:  AIDS       Date:  2020-07-15       Impact factor: 4.177

2.  Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.

Authors:  Laurent Mandelbrot; Pierre-François Ceccaldi; Dominique Duro; Minh Lê; Lucile Pencolé; Gilles Peytavin
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

3.  Prevalence of neural tube defects, maternal HIV status, and antiretroviral therapy from a hospital-based birth defect surveillance in Kampala, Uganda.

Authors:  Linda Barlow-Mosha; Robert Serunjogi; Dennis Kalibbala; Daniel Mumpe-Mwanja; Dhelia Williamson; Diana Valencia; Sarah C Tinker; Joyce Namale Matovu; Cynthia A Moore; Michelle R Adler; Lisa Nelson; Jolly Nankunda; Evelyn Nabunya; Doreen Birabwa-Male; Philippa Musoke
Journal:  Birth Defects Res       Date:  2021-11-11       Impact factor: 2.661

Review 4.  Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

Authors:  Nina Y Yuan; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-06       Impact factor: 4.147

5.  Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.

Authors:  Gerson Fernando Mendes Pereira; Ahra Kim; Emilia M Jalil; Fernanda Fernandes Fonseca; Bryan E Shepherd; Valdilea G Veloso; Fernanda Rick; Rachel Ribeiro; Maria Cristina Pimenta; Andrea Beber; Renato Girade Corrêa; Renato Lima; Fernanda Maruri; Catherine C McGowan; Adele Schwartz Benzaken; Beatriz Grinsztejn; Jessica L Castilho
Journal:  Lancet HIV       Date:  2021-01       Impact factor: 12.767
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.